

Netflix won the streaming wars, Pimp my Portfolio with Luke Laretive & we debate Novo Nordisk or Eli Lilly
10 snips Feb 16, 2025
In this discussion, financial expert Luke Laretive takes a deep dive into the streaming wars, declaring Netflix the victor over Disney. He also analyses the competitive landscape of GLP-1 drugs, weighing Eli Lilly against Novo Nordisk. Luke shares insights on how market trends are affecting Australian offices and discusses the potential impacts of sports victories on stock markets. Finally, he provides tailored portfolio strategies, emphasizing the importance of diversification and adapting to changing market dynamics.
AI Snips
Chapters
Transcript
Episode notes
Netflix Wins Streaming Wars
- Netflix has emerged victorious in the streaming wars, boasting triple the subscribers of its closest competitors.
- Their success is evident in their impressive subscriber growth, pricing power, and lower churn rate.
Netflix's Low Churn Rate
- Netflix's churn rate is remarkably low at 2%, significantly outperforming competitors like Disney+, Apple TV+, and Peacock.
- This indicates strong customer loyalty and engagement with Netflix's content.
Netflix's Global Content Strategy
- Netflix invests heavily in international content, with 50% of its spending allocated outside the US.
- This global approach allows Netflix to produce diverse content at a lower cost compared to competitors like Disney.